Departamento de Ciencias Morfolóxicas

2007

1. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

   Neurobiology of Aging, Vol. 28, Núm. 4, pp. 555-567

2. Biocompatibility of agarose gel as a dermal filler: Histologic evaluation of subcutaneous implants

   Plastic and Reconstructive Surgery, Vol. 120, Núm. 5, pp. 1161-1169

3. Botulinum toxin A for treating muscular contractures in cephalic tetanus

   British Journal of Oral and Maxillofacial Surgery, Vol. 45, Núm. 7, pp. 573-575

4. Development of the serotonergic system in the central nervous system of the sea lamprey

   Journal of Chemical Neuroanatomy, Vol. 34, Núm. 1-2, pp. 29-46

5. Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro

   Developmental Neurobiology, Vol. 67, Núm. 12, pp. 1549-1559

6. Estradiol sustained release from high affinity cyclodextrin hydrogels

   European Journal of Pharmaceutics and Biopharmaceutics, Vol. 66, Núm. 1, pp. 55-62

7. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism

   Journal of Endocrinological Investigation, Vol. 30, Núm. 6, pp. 470-476

8. Mechanism of 6-hydroxydopamine neurotoxicity: The role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

   Journal of Neurochemistry, Vol. 103, Núm. 1, pp. 145-156

9. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft

   Brain, Vol. 130, Núm. 5, pp. 1306-1316

10. Oral health status in patients with moderate-severe and terminal renal failure

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 12, Núm. 4, pp. 8

11. Oral health status in patients with moderate-severe and terminal renal failure.

    Medicina oral, patología oral y cirugía bucal, Vol. 12, Núm. 4

12. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma

    Oral Diseases, Vol. 13, Núm. 3, pp. 285-290

13. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors

    Developmental Neurobiology, Vol. 67, Núm. 1, pp. 10-22

14. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP

    Synapse, Vol. 61, Núm. 12, pp. 1006-1012

15. Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease

    Neurochemical Research, Vol. 32, Núm. 1, pp. 99-105

16. Varón de 70 años con lesiones ulceradas en la pared torácica

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 10, pp. 651-652

17. Vitamin D, Pit-1 GH, and PRL: Possible roles in breast cancer development

    Current Medicinal Chemistry, Vol. 14, Núm. 29, pp. 3051-3058